公司新闻
2024年04月18日
江苏苏州及美国消息(2024年4月16日)-江苏新元素医药科技有限公司(新元素医药,Atom Bioscience)是一家致力于治疗代谢和抗炎领域疾病的创新药物研发企业,今天宣布胡贤君先生自2024年4月16日起加入新元素医药,担任临床副总裁,他将全面负责中国临床事务。...
2024年01月19日
JANUARY 02, 2024 JIANGSU, China–January 2, 2024 –Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical...
2024年01月19日
OCTOBER 16, 2023 JIANGSU, China–October 16, 2023–Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical...
2024年01月19日
Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
OCTOBER 9, 2023 JIANGSU, China–Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.),...
2023年09月22日
May 24, 2023 By: Ben Adams Atom Bioscience wants people to see that gout is more that just...
2023年09月22日
Gout Myths—Busted It’s more your genes and less your lifestyle, say our experts. Aug 11, 2022 ...
2023年09月22日
Published: Mar 21, 2022 Preliminary data suggest Atom’s compound reduces uric acid levels to prevent...
2023年05月22日
PRESS RELEASE Atom Bioscience Marks Gout Awareness Day by Urging Increased Patient Education on Debilitating...
2023年04月03日
PRESS RELEASE Atom Bioscience Names UC San Diego Professor Robert Terkeltaub, M.D., to its Scientific...
2023年03月01日
PRESS RELEASE Atom Bioscience Announces Positive Results of Phase 2a China Clinical Trial of Its URAT1...
2023年02月01日
PRESS RELEASE Atom Bioscience to Present at BIO CEO & Investor Conference on February 6, 2023, at...
2023年01月25日
PRESS RELEASE Atom Bioscience Names Stanford University Professor Vibeke Strand, M.D., to its Scientific...
2022年11月10日
PRESS RELEASE Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic...
2022年09月13日
PRESS RELEASE Atom Bioscience Announces Abstract for Its Phase 2a Gout Study Accepted for American College...
2022年06月08日
PRESS RELEASE Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International...
2022年05月18日
PRESS RELEASE On Gout Awareness Day, Let’s Put the Myths to Rest Genetic abnormalities are the real cause...
2022年03月21日
Gout is genetic disease with a surging patient population worldwide
2022年02月07日
Lead drug targets unmet medical need in chronic gout Provides significant serum uric acid reduction in...
2022年01月06日
Lead drug targets unmet medical need in chronic gout Provides significant efficacy without toxic side...
2022年01月05日
江苏新元素医药科技有限公司近日完成超3亿元人民币的C轮融资,本轮融资由熙诚金睿和高特佳领投,倚锋资本、元禾控股和乾道集团跟投,原股东凯泰资本、丽珠医药、红杉中国继续追加投资。
行业动态
At ABP-671 1mg doses given once daily, 86% of the subjects reached serum uric acid levels that were below...
US veterans with gout have an excess death risk that is largely attributable to comorbidities, particularly...
Arthritis & Rheumatology:Study Compares Gout Treatments with Different Mechanisms of Action – URAT1 Inhibitor vs Xanthine Oxidase Inhibitor
How Gout Flare-ups May Increase the Risk of Heart Attack, Stroke Gout is a type of arthritis caused by...